Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology

BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain cancer, for which curative therapies are not available. An emerging therapeutic approach suggested to have potential to target malignant gliomas has been based on the use of multipotent mesenchymal stem cells (MSCs), either unmodifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira de Castro, Joana, Gomes, Eduardo D., Granja, Sara, Anjo, Sandra I., Baltazar, Fátima, Manadas, Bruno, Salgado, António J., Costa, Bruno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625623/
https://www.ncbi.nlm.nih.gov/pubmed/28969635
http://dx.doi.org/10.1186/s12967-017-1303-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625623/
https://www.ncbi.nlm.nih.gov/pubmed/28969635
http://dx.doi.org/10.1186/s12967-017-1303-8

Ejemplares similares